Trial intelligence / Profile preview

Rotigotine transdermal patch as adjunctive therapy in advanced Parkinson's disease (China, Phase III)

CTR20131225Phase 3Completed

Sponsor
Schwarz Pharma
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by Schwarz Pharma. Started Feb 2015; status: completed.

02

Drugs

rotigotine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on CTR20131225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call